Article
Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients.
The pharmacogenomics journal - 23 Aug 2024
Mohamed Moataz E, Guo Bin, Wu Baolin, Schladt David P, Muthusamy Amutha, Guan Weihua, Abrahante Juan E, Onyeaghala Guillaume, Saqr Abdelrahman, Pankratz Nathan, Agarwal Gaurav, Mannon Roslyn B, Matas Arthur J, Oetting William S, Remmel Rory P, Israni Ajay K, Jacobson Pamala A, Dorr Casey R
Abstract excerpt
African American (AA) kidney transplant recipients (KTRs) have poor outcomes, which may in-part be due to tacrolimus (TAC) sub-optimal immunosuppression. We previously determined the common genetic regulators of TAC pharmacokinetics in AAs which were CYP3A5 *3, *6, and *7. To identify low-frequency variants that impact TAC pharmacokinetics, we used extreme phenotype sampling and compared individuals with extreme...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
